Abeona Therapeutics
ABEO
$4.45
Share price
1.14%
Change (1 day)
39.94%
Change (1 year)
Categories
Operating Margin for Abeona Therapeutics (ABEO)
Operating Margin as of May 2024 (TTM): -1,742.07%
According to Abeona Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -1,742.07%. At the end of 2021 the company had an Operating Margin of -2,708.87%.
Operating Margin history for Abeona Therapeutics from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,708.87% | 238.11% |
| 2020 | -801.19% | |
| 2018 | -1,889.93% | -42.08% |
| 2017 | -3,262.96% | 32.66% |
| 2016 | -2,459.73% | 76.18% |
| 2015 | -1,396.15% | -50.7% |
| 2014 | -2,832.00% | -1323.13% |
| 2013 | 231.54% | -202.75% |
| 2012 | -225.34% | 168.32% |
| 2011 | -83.98% | -94.79% |
| 2010 | -1,612.68% | -41.33% |
| 2009 | -2,748.86% | -52.21% |
| 2008 | -5,751.55% | -52.49% |
| 2007 | -12,105.26% | |
| 2004 | -1,653.73% | 160.76% |
| 2003 | -634.21% | -16.39% |
| 2002 | -758.50% | -70.78% |
| 2001 | -2,595.88% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Merck MRK | 27.73% | -101.59% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | 13.86% | -100.80% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.